ATE77371T1 - 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung. - Google Patents

3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung.

Info

Publication number
ATE77371T1
ATE77371T1 AT85109689T AT85109689T ATE77371T1 AT E77371 T1 ATE77371 T1 AT E77371T1 AT 85109689 T AT85109689 T AT 85109689T AT 85109689 T AT85109689 T AT 85109689T AT E77371 T1 ATE77371 T1 AT E77371T1
Authority
AT
Austria
Prior art keywords
indoles
analgesics
aminoalkyl
carbonyl
useful
Prior art date
Application number
AT85109689T
Other languages
English (en)
Inventor
Malcolm Rice Bell
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of ATE77371T1 publication Critical patent/ATE77371T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT85109689T 1984-08-06 1985-08-01 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung. ATE77371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63793184A 1984-08-06 1984-08-06
EP85109689A EP0171037B1 (de) 1984-08-06 1985-08-01 3-Carbonyl-1-Aminoalkyl-1H-Indole, verwendbar als Analgetika und ihre Herstellung

Publications (1)

Publication Number Publication Date
ATE77371T1 true ATE77371T1 (de) 1992-07-15

Family

ID=24557949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85109689T ATE77371T1 (de) 1984-08-06 1985-08-01 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung.

Country Status (20)

Country Link
EP (1) EP0171037B1 (de)
JP (1) JPH0670010B2 (de)
KR (1) KR870000548B1 (de)
AR (1) AR244665A1 (de)
AT (1) ATE77371T1 (de)
AU (1) AU574817B2 (de)
DE (1) DE3586224T2 (de)
DK (1) DK170279B1 (de)
ES (5) ES8609246A1 (de)
FI (1) FI852973L (de)
GR (1) GR851937B (de)
IE (1) IE57863B1 (de)
IL (1) IL75966A (de)
MX (4) MX160612A (de)
MY (1) MY101186A (de)
NO (1) NO169067C (de)
NZ (3) NZ225467A (de)
PH (2) PH23498A (de)
PT (1) PT80919B (de)
ZA (1) ZA855923B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
US4840950A (en) * 1987-02-11 1989-06-20 Sterling Drug Inc. 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
US5312829A (en) * 1990-05-21 1994-05-17 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
TW270114B (de) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
CN1382123A (zh) * 1999-08-26 2002-11-27 藤泽药品工业株式会社 吲哚衍生物或其盐的制造方法
JP6493786B2 (ja) * 2015-01-06 2019-04-03 パナソニックＩｐマネジメント株式会社 免疫原、それを用いた抗体の製造方法、及び、そのモノクローナル抗体
JP6435505B2 (ja) * 2015-01-13 2018-12-12 パナソニックＩｐマネジメント株式会社 化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3217011A (en) * 1965-05-07 1965-11-09 Sterling Drug Inc 1-(indolyglyoxalyl)-piperidines
US3494920A (en) * 1967-12-18 1970-02-10 American Home Prod 1-di(lower)alkylamino(lower)alkyl-3-(2-substituted ethyl) indoles
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
FR2354766A1 (fr) * 1976-06-17 1978-01-13 Labaz Derives n-aminoalkyles d'indole et procedes pour les preparer
IL74251A (en) * 1984-02-07 1990-01-18 Pfizer 1,3-disubstituted oxindoles and analgesic and antiinflammatory compositions comprising them

Also Published As

Publication number Publication date
DK354485A (da) 1986-02-07
MY101186A (en) 1991-07-31
NO169067C (no) 1992-05-06
DK170279B1 (da) 1995-07-24
PT80919A (en) 1985-09-01
ES552909A0 (es) 1987-12-01
IE851930L (en) 1986-02-06
NO169067B (no) 1992-01-27
PT80919B (pt) 1987-09-30
ES552910A0 (es) 1987-12-16
PH23498A (en) 1989-08-16
EP0171037A2 (de) 1986-02-12
EP0171037B1 (de) 1992-06-17
NO853066L (no) 1986-02-07
GR851937B (de) 1985-12-05
ES8609246A1 (es) 1986-07-16
ES545894A0 (es) 1986-07-16
IL75966A (en) 1989-08-15
ES8800149A1 (es) 1987-10-16
IE57863B1 (en) 1993-05-05
KR870000548B1 (ko) 1987-03-18
AU4576485A (en) 1986-02-13
MX14432A (es) 1993-08-01
MX14431A (es) 1993-08-01
ES8800901A1 (es) 1987-12-01
IL75966A0 (en) 1985-12-31
ES552912A0 (es) 1987-10-16
FI852973A0 (fi) 1985-08-01
MX14429A (es) 1993-09-01
JPS6147463A (ja) 1986-03-07
KR860001805A (ko) 1986-03-22
AU574817B2 (en) 1988-07-14
PH25360A (en) 1991-05-13
EP0171037A3 (en) 1987-08-26
DE3586224T2 (de) 1993-01-28
MX160612A (es) 1990-03-28
DE3586224D1 (de) 1992-07-23
ES552911A0 (es) 1987-12-01
AR244665A1 (es) 1993-11-30
NZ212953A (en) 1990-02-26
ZA855923B (en) 1986-03-26
JPH0670010B2 (ja) 1994-09-07
ES8801203A1 (es) 1987-12-16
NZ225467A (en) 1990-02-26
DK354485D0 (da) 1985-08-05
NZ225466A (en) 1990-02-26
ES8800902A1 (es) 1987-12-01
FI852973L (fi) 1986-02-07

Similar Documents

Publication Publication Date Title
DE3768922D1 (de) Anthrapyridon-verbindungen, ihre herstellung und ihre verwendung.
DE3578418D1 (de) Chinonderivate, ihre herstellung und verwendung.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
ATE63110T1 (de) Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
DE3777604D1 (de) Makrolid-verbindungen, ihre herstellung und ihre verwendung.
DE3580432D1 (de) Hochmolekulare polyester, ihre herstellung und verwendung.
DE3784602D1 (de) Inonos-derivate, ihre herstellung und verwendung.
ATE77371T1 (de) 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3581981D1 (de) Polysaccharid-ron-substanz, ihre herstellung und verwendung.
DE3676218D1 (de) Trimethylcyclohexen-derivate, ihre herstellung und deren verwendung als duftstoffe.
DE68908389D1 (de) Amidofluoroverbindungen, ihre herstellung und ihre verwendung.
ATE45164T1 (de) Steroido(3,2-c>-pyrazole, als antiandrogene und ihre herstellung.
DE3685743D1 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
DE3671892D1 (de) (2-cyano-2-arylethyl)-pyridine, ihre herstellung und verwendung als fungizide.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
DE3879328D1 (de) Stannosilikate, ihre herstellung und verwendung.
DE58908912D1 (de) Polytetrahydrofuranvinylether und ihre Herstellung.
DE3578557D1 (de) Substituierte thiophen-2-sulfonamide und ihre herstellung.
DE3680948D1 (de) Isocyanatverbindungen und ihre herstellung.
DE3584156D1 (de) Gif-2 und dessen herstellung.
DE3770299D1 (de) 1,2,4-triazinonderivate, ihre herstellung und verwendung.
DE3381241D1 (de) 1-diorganocarbamoyl-polyalkylpiperidine und ihre herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee